Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UK

NCT00995995 · clinicaltrials.gov ↗

COMPLETED

Status

7641

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Rosiglitazone

Sponsor

GlaxoSmithKline